Stockwatch: Runners And Riders In The Coronavirus Stakes
Generalist Investors Among Possible Losers In The Pandemic
With so many companies developing treatments and vaccines against coronavirus, and most other affected by the pandemic, they can’t all be winners.
You may also be interested in...
Progress for two US-based companies in the race to develop a COVID-19 vaccine.
An official announcement is expected within weeks, as competition between US and China stokes fears of 'vaccine nationalism'.
While the stock prices of a few biotech companies have advanced significantly as a result of their pandemic efforts, a broad biotech stock index has underperformed the pharmaceutical index. Why?